| 1 |
35487592 | The mineralocorticoid receptor signal could be a new molecular target for the treatment of diabetic retinal complication. | 2022 May |
1 |
| 2 |
33214722 | Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone. | 2021 Apr |
1 |
| 3 |
33570024 | [Pseudohyperaldosteronism with severe hypokalaemia and focal paresis triggered by licorice tea]. | 2021 Feb 8 |
1 |
| 4 |
34889107 | Heightened Cardiovascular Risk in Hypertension Associated With Renin-Independent Aldosteronism Versus Renin-Dependent Aldosteronism: A Collaborative Study. | 2021 Dec 21 |
1 |
| 5 |
34935140 | Mineralocorticoid receptors in non-alcoholic fatty liver disease. | 2021 Dec 22 |
1 |
| 6 |
31599747 | Mitigating risk of aldosterone in diabetic kidney disease. | 2020 Jan |
1 |
| 7 |
31919958 | Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction. | 2020 Aug |
1 |
| 8 |
29982819 | Liquorice, Liddle, Bartter or Gitelman-how to differentiate? | 2019 Jan 1 |
2 |
| 9 |
30854950 | Mineralocorticoid Receptor Antagonists in Primary Aldosteronism. | 2018 |
1 |
| 10 |
27823598 | Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials). | 2017 Jan 15 |
2 |
| 11 |
28073850 | Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure. | 2017 Jan |
1 |
| 12 |
26905224 | Safety and cardiovascular effects of mineralocorticoid receptor antagonists for patients receiving hemodialysis: a systematic review and meta-analysis. | 2016 |
1 |
| 13 |
25616098 | Impact of mineralocorticoid receptor polymorphisms on urinary electrolyte excretion with and without diuretic drugs. | 2015 Jan |
1 |
| 14 |
25784710 | Cardiovascular actions of mineralocorticoid receptor antagonists in patients with chronic kidney disease: A systematic review and meta-analysis of randomized trials. | 2015 Sep |
1 |
| 15 |
26385038 | Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure. | 2015 Sep |
1 |
| 16 |
25016402 | Aldosterone and volume management in hypertensive heart disease. | 2014 May |
1 |
| 17 |
23171954 | Mineralocorticoid receptor antagonists: their use and differentiation in Japan. | 2013 Mar |
1 |
| 18 |
23774812 | Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. | 2013 Aug |
1 |
| 19 |
27122708 | Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems. | 2013 May |
2 |
| 20 |
21799445 | Genetic variants in the renin-angiotensin-aldosterone system and blood pressure responses to potassium intake. | 2011 Sep |
1 |
| 21 |
20030467 | Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. | 2010 Jan |
3 |
| 22 |
20583536 | Primary aldosteronism and its impact on the generation of arterial hypertension, endothelial injury and oxidative stress. | 2010 Apr |
2 |
| 23 |
16972228 | Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. | 2007 Jan |
1 |
| 24 |
16503757 | The aldosterone receptor--new insights? | 2006 Mar |
1 |
| 25 |
15998706 | Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. | 2005 Aug |
1 |
| 26 |
15212727 | Aldosterone Receptor Blockers in the Treatment of Heart Failure. | 2004 Aug |
2 |
| 27 |
12693733 | Aldosterone as a target in congestive heart failure. | 2003 Mar |
1 |
| 28 |
12015312 | Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. | 2002 Jul 19 |
1 |
| 29 |
25905305 | Aldosterone Deficiency and Resistance | 2000 |
2 |
| 30 |
8191539 | Isozymes of 11 beta-hydroxysteroid dehydrogenase: which enzyme endows mineralocorticoid specificity? | 1994 Feb |
1 |